首页 > 最新文献

中华男科学杂志最新文献

英文 中文
[Progress in gene-modified stem cell therapy for penile erectile dysfunction]. [基因修饰干细胞治疗阴茎勃起功能障碍的进展]。
Q4 Medicine Pub Date : 2024-04-01
Dao-Yuan Hu, Heng-Jun Xiao

Erectile dysfunction (ED) is a common disorder in men and lacks effective treatment. Stem cell (SC) possess the potential in self-renewal and multi-directional differentiation, and secrete a variety of active substances. Stem cell therapy, as a promising option for the treatment of ED, is a focus in regenerative medicine research. However, the effect of stem cell therapy alone on ED is limited due to the complexity of the condition and the limitations of SC. Gene modification can enhance the performance of SC in multiple aspects and play the role of targeted genes, and therefore can better improve ED and its related pathological changes than SC therapy alone. In recent years, gene-modified stem cell therapy has become a hotspot in andrological research. This review summarizes the advances in the studies of gene-modified SC in the treatment of ED, aiming to provide some ideas for further research.

勃起功能障碍(ED)是一种常见的男性疾病,缺乏有效的治疗方法。干细胞(SC)具有自我更新和多向分化的潜能,并能分泌多种活性物质。干细胞疗法作为治疗男性性功能障碍的一种有前景的选择,是再生医学研究的一个重点。然而,由于 ED 病情的复杂性和干细胞疗法的局限性,单纯的干细胞疗法对 ED 的治疗效果有限。基因修饰能从多方面提高干细胞的性能,发挥靶向基因的作用,因此比单纯的干细胞疗法能更好地改善ED及其相关病理改变。近年来,基因修饰干细胞疗法已成为生殖医学研究的热点。本综述总结了基因修饰干细胞治疗ED的研究进展,旨在为进一步的研究提供一些思路。
{"title":"[Progress in gene-modified stem cell therapy for penile erectile dysfunction].","authors":"Dao-Yuan Hu, Heng-Jun Xiao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Erectile dysfunction (ED) is a common disorder in men and lacks effective treatment. Stem cell (SC) possess the potential in self-renewal and multi-directional differentiation, and secrete a variety of active substances. Stem cell therapy, as a promising option for the treatment of ED, is a focus in regenerative medicine research. However, the effect of stem cell therapy alone on ED is limited due to the complexity of the condition and the limitations of SC. Gene modification can enhance the performance of SC in multiple aspects and play the role of targeted genes, and therefore can better improve ED and its related pathological changes than SC therapy alone. In recent years, gene-modified stem cell therapy has become a hotspot in andrological research. This review summarizes the advances in the studies of gene-modified SC in the treatment of ED, aiming to provide some ideas for further research.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Transrectal ultrasonography of intravesical prostatic protrusion and the detection rate of clinically significant prostate cancer]. [膀胱内前列腺突出的经直肠超声波检查和有临床意义的前列腺癌的检出率]。
Q4 Medicine Pub Date : 2024-04-01
Yun Dai, Ying-Dong Xie, Chao-Li Xu, Bin Yang

Objective: To investigate the value of transrectal ultrasonography (TRUS) in the detection of clinically significant prostate cancer (CsPCa) in patients with intravesical prostatic protrusion (IPP).

Methods: We retrospectively analyzed the data on 128 patients undergoing TRUS-guided prostate biopsy in the General Hospital of Eastern Theater Command and Jiangsu Province Hospital from January 2019 to December 2022. We measured the size of and graded IPP, compared the clinicopathological and ultrasonographic features of the patients in the CsPCa group (Gleason score ≥7) and those in the control group (Gleason score <7), and analyzed the correlation of the IPP grades with the detection rate of CsPCa by multivariate logistic regression analysis.

Results: The prostate volume was significantly higher in the CsPCa group than in the control ([51.3±12.1] vs [43.5±11.3] ml, P< 0.05), while the PSA density (PSAD) remarkably lower in the former than in the latter ([0.45±1.92] vs [0.59±2.14] ng/ml, P< 0.05) and so was the detection rate of CsPCa in the patients with IPP grade 3 than in those with IPP grades 0, 1 and 2 (56.0% vs 85.4%, 87.1% and 80.6%, P< 0.05). Spearman correlation analysis showed that the Gleason score was correlated positively with the prostate volume (r = 0.612) but negatively with PSAD (r = -0.735) and the IPP grade (r = -0.619) (P< 0.05). Logistic regression analysis indicated that IPP grade 3 (OR: 0.690, 95% CI: 0.380-0.995, P = 0.032) was an independent protective factor for CsPCa.

Conclusion: CsPCa is significantly correlated with the IPP grade, and the detection rate of CsPCa by TRUS-guided biopsy is lower in patients with IPP grade 3 than in those with IPP grades 0-2. Therefore, special attention should be paid to false negative probability in case of high-grade IPP.

目的研究经直肠超声(TRUS)在前列腺膀胱内突出(IPP)患者中发现有临床意义的前列腺癌(CsPCa)的价值:我们回顾性分析了2019年1月至2022年12月在东部战区司令部总医院和江苏省医院接受TRUS引导下前列腺活检的128例患者的数据。我们测量了IPP的大小并进行了分级,比较了CsPCa组(Gleason评分≥7分)和对照组(Gleason评分 结果:CsPCa组患者的临床病理和超声特征明显优于对照组:CsPCa组的前列腺体积明显高于对照组([51.3±12.1] vs [43.5±11.3]ml,P< 0.05),而前者的PSA密度(PSAD)明显低于后者([0.45±1.92] vs [0.59±2.14]ng/ml,P< 0.05),IPP 3级患者的CsPCa检出率也明显低于IPP 0、1和2级患者(56.0% vs 85.4%、87.1%和80.6%,P< 0.05)。斯皮尔曼相关分析显示,Gleason评分与前列腺体积呈正相关(r = 0.612),但与PSAD(r = -0.735)和IPP分级(r = -0.619)呈负相关(P< 0.05)。逻辑回归分析表明,IPP 3级(OR:0.690,95% CI:0.380-0.995,P = 0.032)是CsPCa的独立保护因素:结论:CsPCa与IPP分级明显相关,TRUS引导下活检的CsPCa检出率在IPP分级为3级的患者中低于IPP分级为0-2级的患者。因此,应特别注意高级别 IPP 的假阴性概率。
{"title":"[Transrectal ultrasonography of intravesical prostatic protrusion and the detection rate of clinically significant prostate cancer].","authors":"Yun Dai, Ying-Dong Xie, Chao-Li Xu, Bin Yang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the value of transrectal ultrasonography (TRUS) in the detection of clinically significant prostate cancer (CsPCa) in patients with intravesical prostatic protrusion (IPP).</p><p><strong>Methods: </strong>We retrospectively analyzed the data on 128 patients undergoing TRUS-guided prostate biopsy in the General Hospital of Eastern Theater Command and Jiangsu Province Hospital from January 2019 to December 2022. We measured the size of and graded IPP, compared the clinicopathological and ultrasonographic features of the patients in the CsPCa group (Gleason score ≥7) and those in the control group (Gleason score <7), and analyzed the correlation of the IPP grades with the detection rate of CsPCa by multivariate logistic regression analysis.</p><p><strong>Results: </strong>The prostate volume was significantly higher in the CsPCa group than in the control ([51.3±12.1] vs [43.5±11.3] ml, P< 0.05), while the PSA density (PSAD) remarkably lower in the former than in the latter ([0.45±1.92] vs [0.59±2.14] ng/ml, P< 0.05) and so was the detection rate of CsPCa in the patients with IPP grade 3 than in those with IPP grades 0, 1 and 2 (56.0% vs 85.4%, 87.1% and 80.6%, P< 0.05). Spearman correlation analysis showed that the Gleason score was correlated positively with the prostate volume (r = 0.612) but negatively with PSAD (r = -0.735) and the IPP grade (r = -0.619) (P< 0.05). Logistic regression analysis indicated that IPP grade 3 (OR: 0.690, 95% CI: 0.380-0.995, P = 0.032) was an independent protective factor for CsPCa.</p><p><strong>Conclusion: </strong>CsPCa is significantly correlated with the IPP grade, and the detection rate of CsPCa by TRUS-guided biopsy is lower in patients with IPP grade 3 than in those with IPP grades 0-2. Therefore, special attention should be paid to false negative probability in case of high-grade IPP.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comprehensive intervention combined with cognitive psychological care based on quality chain for patients with benign prostatic hyperplasia]. [基于质量链的良性前列腺增生患者综合干预与认知心理护理相结合]。
Q4 Medicine Pub Date : 2024-04-01
Wen-Zhen Shi, Hong-Yun Chen, Fen Wang

Objective: To investigate the application effect of comprehensive intervention combined with cognitive psychological care based on the quality chain in patients with BPH.

Methods: We prospectively selected 110 cases of BPH treated in our hospital from January 2022 to March 2023 and equally randomized them into groups A and B, the former given routine intervention, while the latter comprehensive intervention combined with cognitive psychological care based on the quality chain in addition. We analyzed the results of intervention, the patients' scores on Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS), improvement of clinical indicators, self-efficacy, disease awareness and treatment compliance, and compared the data obtained between the two groups of patients.

Results: The effectiveness of intervention was significantly better in group B than in A (96.36% vs 65.45%, χ2 = 17.009, P<0.05). Compared with the baseline, the SAS and SDS scores were remarkably improved in the two groups after intervention (P<0.05), even more significantly in group B than in A (P<0.05). Group B also showed a markedly shorter duration of bladder spasm, lower frequency of bladder spasm per day, shorter urethral catheterization time and postoperative hospital stay, better emotion control and health management, more regular schedule, higher disease knowledge awareness, and better treatment compliance than group A (all P<0.05).

Conclusion: Comprehensive intervention combined with cognitive psychological care based on the quality chain is significantly effective in improving BPH patients' clinical indicators, disease awareness and treatment compliance, reducing their depression and anxiety, and enhancing their self-efficacy management.

摘 要探讨基于质量链的综合干预联合认知心理护理在良性前列腺增生患者中的应用效果:前瞻性选取我院2022年1月-2023年3月收治的110例良性前列腺增生症患者,将其平均随机分为A、B两组,前者给予常规干预,后者在此基础上给予基于质量链的综合干预联合认知心理护理。我们分析了干预效果、患者焦虑自评量表(SAS)和抑郁自评量表(SDS)评分、临床指标改善情况、自我效能感、疾病认知度和治疗依从性,并比较了两组患者获得的数据:结果:B组的干预效果明显优于A组(96.36% vs 65.45%,χ2 = 17.009,PC结论:基于质量链的综合干预与认知心理护理相结合,对改善良性前列腺增生患者的临床指标、疾病认知和治疗依从性,减轻其抑郁和焦虑,提高其自我效能管理有明显效果。
{"title":"[Comprehensive intervention combined with cognitive psychological care based on quality chain for patients with benign prostatic hyperplasia].","authors":"Wen-Zhen Shi, Hong-Yun Chen, Fen Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the application effect of comprehensive intervention combined with cognitive psychological care based on the quality chain in patients with BPH.</p><p><strong>Methods: </strong>We prospectively selected 110 cases of BPH treated in our hospital from January 2022 to March 2023 and equally randomized them into groups A and B, the former given routine intervention, while the latter comprehensive intervention combined with cognitive psychological care based on the quality chain in addition. We analyzed the results of intervention, the patients' scores on Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS), improvement of clinical indicators, self-efficacy, disease awareness and treatment compliance, and compared the data obtained between the two groups of patients.</p><p><strong>Results: </strong>The effectiveness of intervention was significantly better in group B than in A (96.36% vs 65.45%, χ2 = 17.009, P<0.05). Compared with the baseline, the SAS and SDS scores were remarkably improved in the two groups after intervention (P<0.05), even more significantly in group B than in A (P<0.05). Group B also showed a markedly shorter duration of bladder spasm, lower frequency of bladder spasm per day, shorter urethral catheterization time and postoperative hospital stay, better emotion control and health management, more regular schedule, higher disease knowledge awareness, and better treatment compliance than group A (all P<0.05).</p><p><strong>Conclusion: </strong>Comprehensive intervention combined with cognitive psychological care based on the quality chain is significantly effective in improving BPH patients' clinical indicators, disease awareness and treatment compliance, reducing their depression and anxiety, and enhancing their self-efficacy management.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Status quo of ED-related studies in China: A bibliometric analysis]. [中国 ED 相关研究的现状:文献计量分析]。
Q4 Medicine Pub Date : 2024-04-01
Jia-Cheng Yu, Xiao-du Xie, Pei-He Liang

Objective: To summarize and visualize the status quo, future hotspots and development trend of ED-related researches in China through bibliometric analysis.

Methods: We searched the Web of Science Core Collection (WOSCC) and the database of Chinese National Knowledge Infrastructure (CNKI) for ED-related studies published in China from January 1, 2010 to August 14, 2023. Using the CiteSpace and VOSviewer softwares, we bibliometrically analyzed and visualized the related journals, regions, institutions, authors, key words, co-citations and other indexes of the identified studies.

Results: A total of 2,465 ED-related studies were retrieved, with an increasing number of publications year by year, relatively more in the southeast region, with Sun Yat-sen University ranking the first in the number of published articles (n = 169), LIU Jihong (n = 73), WANG Tao (n = 71) and JIANG Rui (n = 49) as the top three prolific core authors. The first two Chinese journals with the most ED-related publications were Chinese Journal of Andrology (n = 320) and Journal of Sexual Medicine (n = 128), and the latter was also the mostly cited (n = 5 060). Keyword co-occurrence analysis showed that the highest-frequency Chinese terms included impotence, anxiety, andrology, expert consensus, experience of famous doctors, acupuncture, Earthworm protein (Chinese) and hypertension, and the English terms included erectile dysfunction, apoptosis, inflammation, fibrosis, risk and women.

Conclusion: Recent years have wit-nessed a rapid development in ED-related studies in China, with the risk factors and patho-genic mechanisms of ED as hot topics. PDE5 inhibitors and adipose-derived stem cells for the treatment of ED have attracted long and continuous attention and will remain an important target of future research.

目的通过文献计量学分析,总结中国ED相关研究的现状、未来热点和发展趋势:方法:我们检索了 Web of Science Core Collection(WOSCC)和中国国家知识基础设施(CNKI)数据库中 2010 年 1 月 1 日至 2023 年 8 月 14 日在中国发表的 ED 相关研究。利用CiteSpace和VOSviewer软件,我们对所发现研究的相关期刊、地区、机构、作者、关键词、共被引和其他索引进行了文献计量学分析和可视化:共检索到2465篇ED相关研究,发表数量逐年增加,东南地区相对较多,其中中山大学发表文章数量排名第一(169篇),刘继红(73篇)、王涛(71篇)和姜瑞(49篇)为前三位高产核心作者。发表ED相关论文最多的前两种中文期刊是《中华男性学杂志》(320篇)和《性医学杂志》(128篇),后者也是被引用最多的(5060篇)。关键词共现分析显示,出现频率最高的中文词汇包括阳痿、焦虑、andrology、专家共识、名医经验、针灸、蚯蚓蛋白(中文)和高血压,英文词汇包括勃起功能障碍、细胞凋亡、炎症、纤维化、风险和女性:结论:近年来,中国的ED相关研究发展迅速,ED的危险因素和病理基因机制成为热点话题。PDE5抑制剂和脂肪源性干细胞治疗ED已引起长期持续的关注,仍将是未来研究的重要目标。
{"title":"[Status quo of ED-related studies in China: A bibliometric analysis].","authors":"Jia-Cheng Yu, Xiao-du Xie, Pei-He Liang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To summarize and visualize the status quo, future hotspots and development trend of ED-related researches in China through bibliometric analysis.</p><p><strong>Methods: </strong>We searched the Web of Science Core Collection (WOSCC) and the database of Chinese National Knowledge Infrastructure (CNKI) for ED-related studies published in China from January 1, 2010 to August 14, 2023. Using the CiteSpace and VOSviewer softwares, we bibliometrically analyzed and visualized the related journals, regions, institutions, authors, key words, co-citations and other indexes of the identified studies.</p><p><strong>Results: </strong>A total of 2,465 ED-related studies were retrieved, with an increasing number of publications year by year, relatively more in the southeast region, with Sun Yat-sen University ranking the first in the number of published articles (n = 169), LIU Jihong (n = 73), WANG Tao (n = 71) and JIANG Rui (n = 49) as the top three prolific core authors. The first two Chinese journals with the most ED-related publications were Chinese Journal of Andrology (n = 320) and Journal of Sexual Medicine (n = 128), and the latter was also the mostly cited (n = 5 060). Keyword co-occurrence analysis showed that the highest-frequency Chinese terms included impotence, anxiety, andrology, expert consensus, experience of famous doctors, acupuncture, Earthworm protein (Chinese) and hypertension, and the English terms included erectile dysfunction, apoptosis, inflammation, fibrosis, risk and women.</p><p><strong>Conclusion: </strong>Recent years have wit-nessed a rapid development in ED-related studies in China, with the risk factors and patho-genic mechanisms of ED as hot topics. PDE5 inhibitors and adipose-derived stem cells for the treatment of ED have attracted long and continuous attention and will remain an important target of future research.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Causal relationship between obesity and male infertility: A two-sample Mendelian randomization study]. [肥胖与男性不育之间的因果关系:双样本孟德尔随机研究]。
Q4 Medicine Pub Date : 2024-04-01
Zhi-Chao Li, Zhi-Hai Teng, Zhen-Wei Han, Yan-Ping Zhang, Cheng-Gen Jin, Ya-Xuan Wang

Objective: To clarify the causal relationship between obesity and male infertility through Mendelian randomization (MR) study.

Methods: We assessed the causal effect of genetically predicted body mass index (BMI) on the risk of male infertility via a two-sample MR analysis, with the BMIs of 99 998 cases and 12 746 controls as the exposure factor and genetic information on male infertility obtained from a genome-wide association study of 73 479 Europeans. In the univariable MR (UVMR) analysis of the causal relationship, we mainly used inverse variance weighting (IVW), with MR-Egger regression and weighted median filtering as the supplementary methods. Sensitivity analyses including the Cochran's Q test, Egger intercept test, MR-PRESSO, leave-one-out analysis and funnel plot were performed to verify the robustness of the MR results. To evaluate the direct causal effects of BMI on MI risk, multivariable MR (MVMR) was performed.

Results: UVMR indicated a causal relationship between genetically predicted BMI and an increased risk of male infertility (OR: 1.237, 95% CI: 1.090-1.404, P = 0.001). Sensitivity analysis revealed little evidence of bias in the current study (P> 0.05). With such risk factors as type 2 diabetes, alcohol consumption and smoking adjusted, MVMR confirmed a direct causal effect of genetically predicted BMI on the risk of male infertility (P<0.05).

Conclusion: Genetically predicted BMI may be associated with an increased risk of male infertility. Further studies are expected to explore the underlying mechanisms of this association and provide some new strategies for the prevention and treatment of BMI-related male infertility.

目的:通过孟德尔随机研究(MR)阐明肥胖与男性不育之间的因果关系:通过孟德尔随机化(Mendelian randomization,MR)研究阐明肥胖与男性不育之间的因果关系:我们以99 998例病例和12 746例对照的体重指数作为暴露因子,并从73 479名欧洲人的全基因组关联研究中获得了男性不育的遗传信息,通过双样本MR分析评估了遗传预测体重指数(BMI)对男性不育风险的因果效应。在对因果关系的单变量磁共振(UVMR)分析中,我们主要采用了反方差加权(IVW),并以磁共振-Egger回归和加权中值过滤作为辅助方法。我们还进行了包括 Cochran's Q 检验、Egger 截距检验、MR-PRESSO、leave-one-out 分析和漏斗图在内的敏感性分析,以验证 MR 结果的稳健性。为评估体重指数对心肌梗死风险的直接因果效应,进行了多变量磁共振(MVMR)分析:UVMR表明,遗传预测的体重指数与男性不育风险增加之间存在因果关系(OR:1.237,95% CI:1.090-1.404,P = 0.001)。敏感性分析显示,目前的研究几乎没有偏倚的证据(P> 0.05)。在对 2 型糖尿病、饮酒和吸烟等风险因素进行调整后,MVMR 证实了遗传预测体重指数对男性不育风险的直接因果效应(结论:遗传预测体重指数可能与男性不育风险有关:遗传预测的体重指数可能与男性不育风险的增加有关。进一步的研究有望探索这种关联的内在机制,并为预防和治疗与 BMI 相关的男性不育症提供一些新策略。
{"title":"[Causal relationship between obesity and male infertility: A two-sample Mendelian randomization study].","authors":"Zhi-Chao Li, Zhi-Hai Teng, Zhen-Wei Han, Yan-Ping Zhang, Cheng-Gen Jin, Ya-Xuan Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To clarify the causal relationship between obesity and male infertility through Mendelian randomization (MR) study.</p><p><strong>Methods: </strong>We assessed the causal effect of genetically predicted body mass index (BMI) on the risk of male infertility via a two-sample MR analysis, with the BMIs of 99 998 cases and 12 746 controls as the exposure factor and genetic information on male infertility obtained from a genome-wide association study of 73 479 Europeans. In the univariable MR (UVMR) analysis of the causal relationship, we mainly used inverse variance weighting (IVW), with MR-Egger regression and weighted median filtering as the supplementary methods. Sensitivity analyses including the Cochran's Q test, Egger intercept test, MR-PRESSO, leave-one-out analysis and funnel plot were performed to verify the robustness of the MR results. To evaluate the direct causal effects of BMI on MI risk, multivariable MR (MVMR) was performed.</p><p><strong>Results: </strong>UVMR indicated a causal relationship between genetically predicted BMI and an increased risk of male infertility (OR: 1.237, 95% CI: 1.090-1.404, P = 0.001). Sensitivity analysis revealed little evidence of bias in the current study (P> 0.05). With such risk factors as type 2 diabetes, alcohol consumption and smoking adjusted, MVMR confirmed a direct causal effect of genetically predicted BMI on the risk of male infertility (P<0.05).</p><p><strong>Conclusion: </strong>Genetically predicted BMI may be associated with an increased risk of male infertility. Further studies are expected to explore the underlying mechanisms of this association and provide some new strategies for the prevention and treatment of BMI-related male infertility.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Omega-3 polyunsaturated fatty acids for the treatment of oligoasthenozoospermia: Progress in research]. [奥米加-3 多不饱和脂肪酸治疗少精症:研究进展]。
Q4 Medicine Pub Date : 2024-04-01
Zhou Li, Jun Jing, Xue-Jun Shang, Bing Yao

Oligoasthenozoospermia (OAS) is one of the most common types of male infertility, which, however, still lacks effective treatment. An increasing number of studies have shown the potential therapeutic value of omega-3 polyunsaturated fatty acid (ω-3 PUFA) in the treatment of OAS. This article presents an overview of the studies on the effects of ω-3 PUFA on fatty acid composition and metabolism, inflammatory response, and oxidative stress in OAS, hoping to provide some new ideas for the treatment of the disease.

少精子症(OAS)是男性不育症中最常见的类型之一,但目前仍缺乏有效的治疗方法。越来越多的研究表明,ω-3 多不饱和脂肪酸(ω-3 PUFA)在治疗少精子症方面具有潜在的治疗价值。本文概述了有关ω-3 PUFA对OAS中脂肪酸组成和代谢、炎症反应和氧化应激影响的研究,希望能为该病的治疗提供一些新思路。
{"title":"[Omega-3 polyunsaturated fatty acids for the treatment of oligoasthenozoospermia: Progress in research].","authors":"Zhou Li, Jun Jing, Xue-Jun Shang, Bing Yao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Oligoasthenozoospermia (OAS) is one of the most common types of male infertility, which, however, still lacks effective treatment. An increasing number of studies have shown the potential therapeutic value of omega-3 polyunsaturated fatty acid (ω-3 PUFA) in the treatment of OAS. This article presents an overview of the studies on the effects of ω-3 PUFA on fatty acid composition and metabolism, inflammatory response, and oxidative stress in OAS, hoping to provide some new ideas for the treatment of the disease.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Causes of missed diagnosis of clinically significant prostate cancer by targeted biopsy]. [靶向活检漏诊有临床意义的前列腺癌的原因]。
Q4 Medicine Pub Date : 2024-04-01
He-Song Jiang, Shan Zhou, Xiao-Bing Niu, Lu Ji

Objective: To retrospectively analyze the causes of missed diagnosis of clinically significant PCa (csPCa) by targeted biopsy (TB).

Methods: This retrospective study included 652 males aged (71.32 ± 16.53) years with elevated PSA and abnormal MRI signals detected in our hospital from June 2018 to December 2020. We further examined the patients by transperineal prostatic TB and systematic biopsy (SB), analyzed the detection rates of PCa and csPCa by TB and SB, and investigated the causes of missed diagnosis of csPCa in TB using the fishbone diagram.

Results: The total detection rate of PCa and csPCa by TB combined with SB was 45.7% (298/652), and that of csPCa was 37.4% (244/652), with 38 cases of csPCa missed in TB, including 23 cases of negative TB and 15 cases of low ISUP grade. The causes of missed diagnosis of csPCa by TB included low MRI image quality, PSA density ≤0.15 ng/ml/cm3, target area <10 mm, and PI-RADS 2 score ≤3. The detection rate of csPCa by TB alone was 31.6%, which was increased by 5.8% (P = 0.027) when TB combined with SB.

Conclusion: TB combined with SB yields a higher detection rate of csPCa than either used alone. Missed diagnosis of csPCa by TB is closely related to the characteristics of tumor and MR image of the target area.

目的回顾性分析靶向活检(TB)漏诊有临床意义的 PCa(csPCa)的原因:本回顾性研究纳入了 2018 年 6 月至 2020 年 12 月在我院发现的 PSA 升高且 MRI 信号异常的 652 名男性,年龄(71.32±16.53)岁。我们通过经会阴前列腺TB和系统活检(SB)对患者进行了进一步检查,分析了TB和SB对PCa和csPCa的检出率,并利用鱼骨图研究了TB漏诊csPCa的原因:TB联合SB对PCa和csPCa的总检出率为45.7%(298/652),csPCa的总检出率为37.4%(244/652),TB漏诊38例csPCa,其中23例为阴性TB,15例为低ISUP分级。TB漏诊 csPCa 的原因包括 MRI 图像质量低、PSA 密度≤0.15 ng/ml/cm3、靶区 结论:与单独使用两种方法相比,TB 联合 SB 能产生更高的 csPCa 检出率。TB 对 csPCa 的漏诊与肿瘤特征和靶区的 MR 图像密切相关。
{"title":"[Causes of missed diagnosis of clinically significant prostate cancer by targeted biopsy].","authors":"He-Song Jiang, Shan Zhou, Xiao-Bing Niu, Lu Ji","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To retrospectively analyze the causes of missed diagnosis of clinically significant PCa (csPCa) by targeted biopsy (TB).</p><p><strong>Methods: </strong>This retrospective study included 652 males aged (71.32 ± 16.53) years with elevated PSA and abnormal MRI signals detected in our hospital from June 2018 to December 2020. We further examined the patients by transperineal prostatic TB and systematic biopsy (SB), analyzed the detection rates of PCa and csPCa by TB and SB, and investigated the causes of missed diagnosis of csPCa in TB using the fishbone diagram.</p><p><strong>Results: </strong>The total detection rate of PCa and csPCa by TB combined with SB was 45.7% (298/652), and that of csPCa was 37.4% (244/652), with 38 cases of csPCa missed in TB, including 23 cases of negative TB and 15 cases of low ISUP grade. The causes of missed diagnosis of csPCa by TB included low MRI image quality, PSA density ≤0.15 ng/ml/cm3, target area <10 mm, and PI-RADS 2 score ≤3. The detection rate of csPCa by TB alone was 31.6%, which was increased by 5.8% (P = 0.027) when TB combined with SB.</p><p><strong>Conclusion: </strong>TB combined with SB yields a higher detection rate of csPCa than either used alone. Missed diagnosis of csPCa by TB is closely related to the characteristics of tumor and MR image of the target area.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Focal therapy combined with immunotherapy for prostate cancer: Advances in studies]. [前列腺癌的局部治疗与免疫治疗相结合:研究进展]。
Q4 Medicine Pub Date : 2024-04-01
Chuan-Guo Zhang, Wei-Sheng Li, Cong Zheng, Wen-Qiang He

Prostate cancer (PCa) ranks as the second most prevalent malignancy among males worldwide at present, and its prevalence keeps rising. Focal therapy not only results in tumor necrosis but also encourages the release of autoantigens originating from the tumor into the bloodstream and activates the host immune system to effectively fight the tumor. However, focal therapy alone may not achieve the total ablation of cancer cells and may cause locoregional recurrence. Immunotherapy, by boosting the body's immune response, destroys tumor cells and prevents immune escape. Recent studies show that focal therapy combined with immunotherapy can produce a better clinical efficacy by enhancing the initial immune response, especially for low- to intermediate-risk confined PCa. This article offers some fresh perspectives on the management of PCa by reviewing the etiology and progression of the malignancy, focal therapeutic options, and advantages and vista of focal therapy combined with immunotherapy.

前列腺癌(PCa)是目前全球男性发病率第二高的恶性肿瘤,而且发病率还在不断上升。病灶治疗不仅能使肿瘤坏死,还能促使肿瘤自身抗原释放到血液中,激活宿主免疫系统有效对抗肿瘤。然而,单纯的病灶治疗可能无法达到完全消融癌细胞的目的,还可能导致局部复发。免疫疗法通过增强机体的免疫反应,摧毁肿瘤细胞,防止免疫逃逸。最近的研究表明,病灶治疗联合免疫治疗可通过增强初始免疫反应产生更好的临床疗效,尤其适用于中低风险的局限性 PCa。本文通过回顾PCa的病因和进展、病灶治疗方案以及病灶治疗联合免疫治疗的优势和前景,为PCa的治疗提供了一些新的视角。
{"title":"[Focal therapy combined with immunotherapy for prostate cancer: Advances in studies].","authors":"Chuan-Guo Zhang, Wei-Sheng Li, Cong Zheng, Wen-Qiang He","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Prostate cancer (PCa) ranks as the second most prevalent malignancy among males worldwide at present, and its prevalence keeps rising. Focal therapy not only results in tumor necrosis but also encourages the release of autoantigens originating from the tumor into the bloodstream and activates the host immune system to effectively fight the tumor. However, focal therapy alone may not achieve the total ablation of cancer cells and may cause locoregional recurrence. Immunotherapy, by boosting the body's immune response, destroys tumor cells and prevents immune escape. Recent studies show that focal therapy combined with immunotherapy can produce a better clinical efficacy by enhancing the initial immune response, especially for low- to intermediate-risk confined PCa. This article offers some fresh perspectives on the management of PCa by reviewing the etiology and progression of the malignancy, focal therapeutic options, and advantages and vista of focal therapy combined with immunotherapy.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Peripheral blood lymphocyte subsets are associated with the prognosis of prostate cancer]. [外周血淋巴细胞亚群与前列腺癌的预后有关]。
Q4 Medicine Pub Date : 2024-04-01
Fei Mao, Chao Yang, Lu Ji

Objective: To explore the relationship between peripheral lymphocyte subsets and the survival of PCa patients.

Methods: Using the Kaplan-Meier curve and log-rank test, we compared the overall survival (OS) and progression-free survival (PFS) of 100 PCa patients with different levels of lymphocytes. Meanwhile, we investigated the prognostic factors by univariate and multivariate Cox regression analyses, and counted the peripheral lymphocyte subsets by flow cytometry.

Results: Both OS and PFS were significantly prolonged in the PCa patients with high levels of lymphocytes (≥747/μl), CD3+T cells (≥528/μl), CD4+T cells (≥315/μl), CD8+T cells (≥226/μl), B cells (≥105/μl) and NK cells (≥168/μl)(P < 0.001). Univariate and multivariate Cox regression analyses indicated that CD4+T cells ≤ 315/μl was an independent factor for the poor prognosis of PCa (HR=12.58, 95% CI: 3.00-52.73).

Conclusion: Decreased absolute count of peripheral lymphocyte subsets is associated with the poor prognosis of PCa.

目的:探讨外周淋巴细胞亚群与 PCa 患者生存率之间的关系:探讨外周淋巴细胞亚群与 PCa 患者生存期之间的关系:采用 Kaplan-Meier 曲线和对数秩检验比较了 100 例不同淋巴细胞水平的 PCa 患者的总生存期(OS)和无进展生存期(PFS)。同时,我们通过单变量和多变量考克斯回归分析研究了预后因素,并通过流式细胞术统计了外周淋巴细胞亚群:淋巴细胞水平高(≥747/μl)、CD3+T细胞(≥528/μl)、CD4+T细胞(≥315/μl)、CD8+T细胞(≥226/μl)、B细胞(≥105/μl)和NK细胞(≥168/μl)的PCa患者的OS和PFS均明显延长(P<0.001)。单变量和多变量Cox回归分析表明,CD4+T细胞≤315/μl是PCa预后不良的独立因素(HR=12.58,95% CI:3.00-52.73):结论:外周淋巴细胞亚群绝对计数的降低与PCa的不良预后有关。
{"title":"[Peripheral blood lymphocyte subsets are associated with the prognosis of prostate cancer].","authors":"Fei Mao, Chao Yang, Lu Ji","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To explore the relationship between peripheral lymphocyte subsets and the survival of PCa patients.</p><p><strong>Methods: </strong>Using the Kaplan-Meier curve and log-rank test, we compared the overall survival (OS) and progression-free survival (PFS) of 100 PCa patients with different levels of lymphocytes. Meanwhile, we investigated the prognostic factors by univariate and multivariate Cox regression analyses, and counted the peripheral lymphocyte subsets by flow cytometry.</p><p><strong>Results: </strong>Both OS and PFS were significantly prolonged in the PCa patients with high levels of lymphocytes (≥747/μl), CD3+T cells (≥528/μl), CD4+T cells (≥315/μl), CD8+T cells (≥226/μl), B cells (≥105/μl) and NK cells (≥168/μl)(P < 0.001). Univariate and multivariate Cox regression analyses indicated that CD4+T cells ≤ 315/μl was an independent factor for the poor prognosis of PCa (HR=12.58, 95% CI: 3.00-52.73).</p><p><strong>Conclusion: </strong>Decreased absolute count of peripheral lymphocyte subsets is associated with the poor prognosis of PCa.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role of seminal vesicles in male sexual function]. [精囊在男性性功能中的作用]。
Q4 Medicine Pub Date : 2024-03-01
Bao-Fang Jin, Da-Lin Sun

The seminal vesicle is an important accessory gland of the male reproductive system. In the past, some scholars focused more on its role in the fertilization process and neglected its relationship with male sexual function. Researches show that the seminal vesicle is involved in multiple processes such as sexual desire, penile erection, and ejaculation. Treatment of sexual dysfunction by medication targeting the seminal vesicle has achieved certain therapeutic effects. This article discusses the relationship between the seminal vesicle and sexual function in terms of physiopathology, clinical study and basic research, hoping to provide some new ideas on the clinical diagnosis and treatment of sexual dysfunction.

精囊是男性生殖系统的重要附属腺体。过去,一些学者更关注它在受精过程中的作用,而忽视了它与男性性功能的关系。研究表明,精囊参与了性欲、阴茎勃起和射精等多个过程。针对精囊的药物治疗性功能障碍取得了一定的疗效。本文从生理病理、临床研究和基础研究等方面探讨了精囊与性功能的关系,希望能为性功能障碍的临床诊断和治疗提供一些新思路。
{"title":"[The role of seminal vesicles in male sexual function].","authors":"Bao-Fang Jin, Da-Lin Sun","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The seminal vesicle is an important accessory gland of the male reproductive system. In the past, some scholars focused more on its role in the fertilization process and neglected its relationship with male sexual function. Researches show that the seminal vesicle is involved in multiple processes such as sexual desire, penile erection, and ejaculation. Treatment of sexual dysfunction by medication targeting the seminal vesicle has achieved certain therapeutic effects. This article discusses the relationship between the seminal vesicle and sexual function in terms of physiopathology, clinical study and basic research, hoping to provide some new ideas on the clinical diagnosis and treatment of sexual dysfunction.</p>","PeriodicalId":24012,"journal":{"name":"Zhonghua nan ke xue = National journal of andrology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华男科学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1